Connect with us

Featured

Dropbox And Spotify In A Sticky Stance To Keep Up New IPOs

Joe Samuel

Published

on

dropbox stock price spotify stock price

After an IPO just last year, Dropbox Inc (DBX) and Spotify Technology (SPOT) already seem to have hit a bit of a snag. They’ve been overshadowed by various new IPOs like Zoom Video, PagerDuty, etc. These new April ’19 entrants have seen the better side of the market. Zoom stock price and PagerDuty stock price have risen by 41% and 29 % respectively over the very short period. 

[Special Report] The Next Big Tech Play Could Be “Hand-Delivered”

The same however cannot be said for either Spotify (flat since its IPO) or Dropbox, whose stock price fell by 15% over the same period. This year has been a little better, with Spotify increasing 27% year to date, and Dropbox up by 17%.

Dropbox Stock Price

With a very slow to almost no revenue growth, Dropbox created a sense of insecurity among the investors. The company had announced earnings much higher than those forecasted over the span of the previous five quarters. In spite of this, it has been unable to increase sales of the company by even a percent during the same period.

Moreover, the growth rate is also beginning to slow down with a projected current year’s growth rate at 18%. This is as compared to last year’s 26%. Meanwhile, sales projected figures indicate a rise by a mere 15%. These figures indicated the company’s vulnerable position in the market.

[Read More] 3 Biotech Stocks To Watch After Big News This Month

In hopes of recovery, the company, on June 11, announced an ‘integrated workspace’. It’s a user interface aimed to hook into document repositories along with connecting to various other enterprise apps, like Slack. Slack is a collaboration tool product of a newly-went public start-up also named Slack. Being far behind in revenue as compared to Dropbox ($600 million for slack while $1.6 billion for Dropbox), Slack still poses a threat to the latter. Forecasts show that Slack’s revenue growth would be over 50%. With the load of new IPOs in the market, Dropbox has to fight much harder.

Dropbox did familiarize the market with the sharing of files. But it somehow remains less famous than Slack, now the go-to app for employees. This does imply the inefficiency of customer relationship management. Additionally, being unable to keep a track record of the new customers, and among the old ones that the company retained and lost. The company is quite behind in its progress based on the retention metrics Wall Street loves to use when dealing with enterprise software.

Spotify Stock Price

Spotify, on the other hand, has a little different story. It has an increasing growth rate of revenue from 20% last year to 27% this year. This rounds out the revenue to $7.7 billion. The Spotify stock price appears low, making the revenue 3.5 times of the stock value. EBITDA of the company has been negative, though, now, the negative figures are decreasing. This could indicate a profit for the firm in 2021. The customer base has been increasing for Spotify. But user count at March-end was up by 26% from the previous year’s figure.

The next year’s report would be out by August 8th for Dropbox and on July 25th for Spotify. It is crucial for both the companies to keep its investors, luring in more at the same time.

Like This Article? Check Out: There’s A New Way To Netflix & Chill In The Stock Market

Continue Reading
Click to comment

Biotechnology

StockPrice.com Subscribers WIN BIG!

Jon Phillip

Published

on

stock price WINNING

We owe you a BIG congratulations. The whole point of StockPrice.com is to bring you important information, first. Sure we send emails out every day on top trending articles and news but we also bring periodic reports on certain companies.

Earlier this year we brought you a full report on a company, PharmaCyte Biotech (PMCB).

Since that report, we’ve watched as PharmaCyte evolved into what it has become today: a biotech powerhouse on the verge of presenting its treatment to the FDA!

Stock Price Subscribers Saw The Full PMCB 90%+ Breakout From August – December; Congratulations! Click Here to Read Our Original Report

This is a great thing for subscribers and we’ve got more featured reports coming! How do you get these reports first?


STEP 1: Make Sure Our Email Address Is In Your Whitelist Address Book So Nothing Gets Lost In Spam

STEP 2:Take Out Your Cell Phone And Text “STOCKPRICE” to 63566. Even If You Miss An Email, We Send Out Updates Directly To Your Cell Phone In Real Time

Again, congratulations to everyone and make sure you stay tuned for our next Stock Price Exclusive Report!




Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 10/15/2019. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 10/16/2019 – 11/15/2019.We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. FULL DISCLAIMER HERE

Continue Reading

Featured

Stock Price Newsletter – December 12, 2019

Joe Samuel

Published

on

penny stocks news

Are These Biotech Stocks To Buy Or Sell Right Now?

One of the sectors that have proven to be a consistently steady performer in the stock market over the past few years is the biotech sector. Hence, it is not really a surprise that investors are almost always on the lookout for the next big thing among biotech stocks.

Click To Read More


The $40 Billion Dollar Content Gold Rush

Apple, Disney, Netflix, Amazon, NBC, Hulu & More are All Competing Within the Global Video Streaming Market and They All Need the Same Thing… New & Original Content! Massive Demand May Create Huge Opportunity for One Company.

See For Yourself


3 Penny Stocks To Watch Before The End of 2019: One Up 308%

Penny stocks have often proven to be one of the best classes of stocks to invest in if you like high risk. These cheap stocks allow investors to get into the stock market with a small capital account and buy thousands or even millions of shares of stock at a time. Since these low priced stocks tend to move by pennies at a time, that slight change can equate to large percentage moves.

Continue Reading

Continue Reading

Featured

3 Penny Stocks To Watch Before The End of 2019: One Up 308%

Jon Phillip

Published

on

stocks to buy now

Penny stocks have often proven to be one of the best classes of stocks to invest in if you like high risk. These cheap stocks allow investors to get into the stock market with a small capital account and buy thousands or even millions of shares of stock at a time. Since these low priced stocks tend to move by pennies at a time, that slight change can equate to large percentage moves.

That being said, investors need to keep in mind that research is key. That’s in order to discover potentially winning trades in the market. Here is a look at the list of penny stocks that could end up on some watch lists this month.

Penny Stocks To Watch #1: Iterum Therapeutics

stocks to watch Iterum Therapeutics

One of the penny stocks that made a significant move on Tuesday was that of Iterum Therapeutics PLC (ITRM Stock Report) and the move came about after the company made a major announcement. The company announced that the Sulopenem for Resistant Enterobacteriaceae (SURE) 3 clinical trial of its product managed to hit the endpoint set by the United States Food and Drug Administration.

The medicine in question is meant for the treatment of complex inter-abdominal infections. The news proved to be a highly positive one for the company and the market thought so as well. ITRM stock rallied by as much as 22% after the news broke and Iterum has emerged as one of the companies that could be tracked for the rest of the week.

Penny Stocks To Watch #2 Technical Communications

stocks to watch Technical Communications Corporation

The other penny stock that went on a massive rally on Tuesday is the Technical Communications Corporation (TCCO Stock Report) stock. The rally came about after the company blew analysts’ estimates out of the water in its third quarter and swung back to profit as well.

After having made losses of $239,000 in the year-ago period, Technical Communications reported profits of $1.03 million and that reflects a remarkable turnaround. The company managed to complete a wide range of overseas contracts and that boosted its earnings. TCCO stock has rallied by as much as 308%.

Penny Stocks To Watch #3 Equillium

stocks to watch Equillium Inc

Lastly, Equillium Inc (EQ Stock Report) has emerged as another penny stock that has recorded impressive gains in recent days. Over the past two weeks, EQ stock has gained as much as 47% and on Wednesday it went up by 10% yet again.

Yesterday, the company announced that its Lupus Nephritis treatment Itolizumab has been granted fast track status by the U.S. FDA and that resulted in a rally in the stock as investors flocked to it pretty quickly. It could be a stock worth watching in the coming days.

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com